COMPREHENSIVE CANCER CENTRE AT MEDICLINIC CITY HOSPITAL
Delivering a Unique Service to Oncology Patients in the UAE

Mediclinic City Hospital's Comprehensive Cancer Centre (CCC), which opened in the new North Wing extension in September 2016, is the UAE’s most advanced facility for the diagnosis and treatment of cancer. It provides a range of facilities and services, supported by the latest generation of equipment, some of which are entirely new not only to the UAE but to the entire MENA region.

Built in collaboration with Mediclinic Middle East’s sister platform in Switzerland, Hirslanden, patients at the CCC can, for the first time in the UAE, benefit from the sharing of knowledge and experience between some of the leading oncology experts in Europe and the Middle East, as well as access to the very latest treatment programmes and technology.

The CCC combines diagnostic procedures with the treatment modalities of surgery, medical oncology and radiation therapy, all under one roof. The value of the service provided by the CCC stems from the quality of the technology and equipment it houses. The CCC offers radiation therapy using the first TrueBeam linear accelerator in the UAE, and the only Varian 13.7 version in the MENA region, using the newest treatment technology of flattening filter free energy.

Gold Sponsor

Myriad Genetics is a leading molecular diagnostic company dedicated to making a difference in patient's lives through the discovery and commercialization of transformative tests to assess a person’s risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence.

Exhibitor


For Sponsorship and Exhibition inquiries, please contact Rakesh.Chhetri@mci-group.com